An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to & lt; 6 years with chronic kidney disease receiving dialysis
ConclusionsIn conclusion, a single 0.25 mg/kg dose of cinacalcet was evaluated to be a safe starting dose in these children aged< 6 years.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
More News: Children | Chronic Kidney Disease | Dialysis | Gastroenterology | Hormones | Hyperparathyroidism | Nasogastric Intubation | Pediatrics | Sensipar | Study | Urology & Nephrology